Home > Boards > US Listed > Biotechs > Sage Therapeutics, Inc. (SAGE)

On this news stock will keep moving higher

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
cvm101 Member Profile
 
Followed By 0
Posts 270
Boards Moderated 0
Alias Born 04/18/18
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/10/2020 10:34:42 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/7/2020 4:54:32 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)  Business Wire - 1/3/2020 4:30:00 PM
Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Monday, January 13, 2020 Business Wire - 12/23/2019 6:30:00 AM
Sage Therapeutics Announces Planned Progression of SAGE-718 to Phase 2 in Huntington's Disease & Presentations at the 2019 An... Business Wire - 12/10/2019 7:30:00 AM
Alphabet, Campbell, Expedia: Stocks That Defined the Week Dow Jones News - 12/6/2019 6:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/5/2019 7:01:45 AM
Sage Therapeutics Reports Topline Results from Pivotal Phase 3 MOUNTAIN Study of SAGE-217 in Major Depressive Disorder Business Wire - 12/5/2019 6:30:00 AM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 12/3/2019 4:30:00 PM
Shareholder Alert: Robbins LLP Is Investigating the Officers & Directors of Sage Therapeutics, Inc. (SAGE) on Behalf of Share... Business Wire - 11/25/2019 6:44:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 7:18:01 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 6:45:22 AM
Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights Pipeline and Business Progress Business Wire - 11/12/2019 6:31:00 AM
Sage Therapeutics to Present at the Stifel 2019 Healthcare Conference Business Wire - 11/11/2019 4:30:00 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 11/5/2019 6:00:00 PM
Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 Business Wire - 10/9/2019 6:30:00 AM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 10/2/2019 4:30:00 PM
Sage Therapeutics to Participate in J.P. Morgan Executive Conference Call Series Business Wire - 10/2/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/12/2019 5:01:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/5/2019 4:34:04 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 9/5/2019 4:31:00 PM
Sage Therapeutics Announces the New England Journal of Medicine Publishes Data from Phase 2 Trial with SAGE-217 in Major Depr... Business Wire - 9/4/2019 5:05:00 PM
Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference Business Wire - 9/3/2019 5:31:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/16/2019 4:04:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 7:17:52 AM
cvm101   Monday, 01/07/19 11:39:48 AM
Re: NYCPuglet post# 73
Post # of 111 
On this news stock will keep moving higher to $200 range by march 1

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist